The human disease autoimmune hepatitis (AIH) is caused by an unremitting immune attack upon hepatocytes that leads to widespread liver destruction and organ failure. 1 While the underlying etiology of AIH remains mysterious, the disease is associated with the presence in liver of numerous CD4 þ T cells expressing high levels of the Th1 cytokines interferon (IFN)-g and tumor necrosis factor (TNF)-a. 2, 3 It is well accepted that genetic susceptibility plays a significant role in the pathogenesis of AIH. Early studies demonstrated that major histocompatibility complex (MHC) haplotype influences disease susceptibility [4] [5] [6] and other studies have confirmed that the MHC haplotype A1-B8-DR3 is an important risk factor for the development of AIH in Northern European populations. 7, 8 The MHC human leukocyte antigen (HLA) DR4 allele appears to be an additional independent risk factor. [8] [9] [10] Since the MHC locus is critically involved in molding and regulating the T-cell repertoire, its prominent involvement is consistent with the autoimmune nature of the disease and the concept that autoreactive T helper 1 (Th1) cells mediate disease pathogenesis. However, most individuals harboring A1-B8-DR3 or DR4 do not develop AIH; conversely not all AIH patients carry these particular MHC haplotypes. 11 It has been hypothesized therefore that additional non-MHC loci may regulate the onset or progression of immune-mediated liver damage in AIH. 12, 13 Evidence supporting this hypothesis has been difficult to obtain principally because of the low prevalence of disease. The principal investigative strategy for identifying AIH susceptibility loci unlinked to MHC is the 'candidate' gene approach involving population-based case-control studies. In this approach, a hypothesis is made regarding the involvement of a gene in the pathogenesis of disease, and investigators then assess the relative frequencies in patient and control populations of allelic polymorphisms of the gene in question. Using this approach, Agarwal et al 14 demonstrated that a particular polymorphism (the presence of G instead of A) at position 49 in exon 1 of the gene encoding the T-cell inhibitory molecule CTLA-4 (located on chromosome 2q33) is found at higher frequency in AIH patients (68%) than in normal subjects (50%). Similar candidate gene approaches have failed to show association of AIH with polymorphisms in genes encoding the cytokines interleukin (IL) -1 or IL-10, or the IL-1 receptor antagonist. 15, 16 Mouse models have been informative in elucidating the genetic bases of the onset, progression, and regulation of organ-specific autoimmune diseases. For example, genetic analyses of nonobese diabetic (NOD) mice, a model for type I diabetes mellitus, have demonstrated the importance of the MHC locus in regulating autoimmune attack upon insulinproducing islet beta cells. Early studies demonstrated that the NOD background MHC class II allele I-A g7 is essential for the development of autoimmune diabetes, as NOD congenic mice in which the I-A g7 allele has been substituted with the I-A b allele fail to develop diabetes. 17 Extensive genetic analyses of a variety of murine autoimmune disease models have demonstrated that both MHC and non-MHC loci contribute to disease susceptibility. [18] [19] [20] In low prevalence multifactorial polygenic diseases, the analysis of genetic susceptibility loci can be greatly facilitated through the use of robust animal model systems. We have recently developed a mouse model of autoimmune hepatocellular injury that shares certain key features with the human disease AIH. BALB/c mice deficient in the immunoregulatory cytokine transforming growth factorbeta1 (TGF-b1) uniformly and predictably develop early-onset aggressive necroinflammatory liver disease before 2 weeks of age. 21 Histologically, hepatic injury is characterized by confluent hepatocellular necrosis associated with a mixed inflammatory infiltrate. Increased numbers of CD4 þ T cells are also detectable in diseased livers by flow cytometry. 22 Hepatic CD4 þ T cells from BALB/c-TGF-b1
mice express high levels of the Th1 cytokine IFN-g. Necroinflammatory liver disease in BALB/c-TGFb1 À/À mice is prevented if mice are rendered deficient either in CD4 þ T cells (through in vivo depletion of CD4 þ T cells, using a subset-specific monoclonal antibody 22 ), or in IFN-g (through the development of BALB/c-TGF-b1 21 This indicates the presence of a genetic locus or loci with background-specific alleles that exert influence in modifying the development and/or progression of necroinflammatory liver disease in TGF-b1-deficient mice.
The TGF-b1 À/À mouse model exhibits a powerful influence of genetic background on autoimmune liver disease. BALB/c mice are inbred and all carry a specific MHC haplotype (d) at H-2, the murine MHC locus. We therefore hypothesized that the BALB/cspecific H-2 d haplotype is essential for the development of organ-specific necroinflammatory liver disease in this murine model of autoimmune hepatocellular injury. We have rigorously tested that hypothesis here, via a genetic 'haplotype-swapping' approach using available H-2 congenic strains extensively backcrossed to the BALB background.
Materials and methods

Mouse Breeding and H-2 Haplotypes
Mice were bred in the Dartmouth Medical School animal care facility, and treated humanely, according to National Institutes of Health (NIH) guidelines. JDG has an approved Dartmouth Medical School IACUC protocol for these studies. For all breeder mice, TGF-b1 genotype was determined by polymerase chain reaction (PCR) using DNA purified from tail snips and confirmed independently by a repeat PCR using DNA from a separate tail snip.
þ /À breeders has been described.
þ /À mice were originally obtained from Tom Doetschman (U. Cincinnati). 21, 23 129/Sv1-TGF-b1 þ /À mice were derived from founder mice of the original targeted deletion of the TGF-b1 gene in 129/Sv1 ES cells. 129/Sv1-TGF-b1 þ /À mice were subsequently bred with CF-1 mice, an outbred strain available from Charles River Laboratories. 129/CF-1-TGF-b1 À/À mice were maintained using the 'advanced intercross line' 24 Subsequent molecular analysis revealed clear differences from C57BL/6 in the H2-T region encoding the non-classical class I gene Tla. 27 The H-2 haplotype of the outbred CF-1 strain appears to be H-2 k . The initially inbred CF-1 strain has been maintained as an outbred strain (permitting genetic drift) for at least the past 30 years (see http://www.criver.com/products/research_models/ documents/Research_Models_2004_catalog_Outbred_ Mice.pdf). In approximately 1994, the H-2 haplotypes of about 100 CF-1 mice were extensively tested at Charles River Laboratories, and all were found to harbor only the H-2 k haplotype (Patricia A Mirley, Charles River Laboratories, personal communication). New H-2 haplotypes may have emerged subsequently in this unmonitored population, through the acquisition of new (ie nontypeable) mutations, but the probability of this is low, as the mutation rate of H2 class I and class II loci has been shown to be no higher, and probably significantly lower than, 1.7 Â 10 À4 per gene per generation. 28 Genomes of the genetically heterogeneous 129/CF-1-TGF-b1 þ /À mice are blends of the inbred 129/Sv1 and outbred CF-1 backgrounds. We anticipated therefore that the H-2 haplotypes of these mice to be some combination of H-2 b , H-2 k , and possibly some nontypeable H-2 haplotypes. Testing the H-2 haplotypes of four male and four female 129/CF-1-TGF-b1 þ /À breeder mice in our colony yielded the results H-2 b þ dÀkÀ for all eight mice (TJK, unpublished), making it likely that H-2 bc is the predominant, and perhaps the only, H-2 haplotype present in this population. However, the presence of non-typeable H-2 haplotypes cannot be definitively ruled out without more extensive testing. 
F1-TGF-b1
À/À pups BALB/c-TGF-b1 þ /À mice were bred with 129/CF-1-TGF-b1 À/À mice to generate F1 pups. Both male (BALB)-female (129/CF-1) and female (BALB)-male (129/CF-1) strategies were used.
TGF-b1 Genotyping
Cages were monitored daily for the birth of new litters, defined as day 0. At 3-5 days of age, pups were permanently marked on the tail using a tattoo kit, and genotyping was done on tail snips from these pups, by PCR using the following primer combination:
0 . This single PCR distinguishes the wild-type, heterozygous, and knockout genotypes. When mice were analyzed at day 11, a repeat tail snip was taken and another PCR was performed to confirm TGF-b1 genotype.
H-2 Haplotyping
RBC-lysed peripheral blood mononuclear cells from potential founder BALB-TGF-b1
þ /À H-2 congenic breeder mice were stained with the following typing reagents:
, as appropriate. Biotinylated antibodies were detected with streptavidin-phycoerythrin. Samples were analyzed by flow cytometry. All breeder mice were tested for H-2 haplotype at least twice.
Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) Analyses
Deeply anesthetized 11-12-day-old pups were decapitated and pooling cervical blood was collected using heparinized capillary tubes. Plasma was recovered from centrifugation of blood in BectonDickinson Vacutainer plasma separator tubes. AST and ALT activity levels in plasma were determined within one hour of collection using a Roche-Hitachi 917 Automatic Analyzer, employing an ultraviolet (UV) kinetic enzymatic assay read at 340 nm.
Histology
After anesthesia and euthanasia of mice, organs (liver, heart, intestine, kidneys, brain) were dissected out and fixed in buffered formalin, followed by paraffin embedding, sectioning, and staining with hematoxylin and eosin (H&E), by routine methods.
Statistical Analyses
Data for plasma enzyme levels were analyzed using Student's unpaired two-tailed t-test, with significance accepted at Po0.05.
Results
We hypothesized that the BALB/c MHC haplotype, H We assessed embryonic viability of TGF-b1
conceptuses. Some TGF-b1 À/À embryos die early in development, through a mechanism involving improper development of the yolk sac vasculature. 29 This phenotype is partially penetrant, and penetrance is dependent upon genetic background. 21, 30 On the BALB/c background, embryonic lethality was observed for some TGF-b1 À/À conceptuses, as we have previously published. 21 BALB/c-TGF-b1
, and BALB.K-TGF-b1 À/À conceptuses all exhibited similar rates of developmental viability (B20%) ( Table 1 ), indicating that H-2 haplotype is not a determinant of the penetrance of this phenotype.
BALB/c-TGF-b1 À/À mice spontaneously develop CD4
þ -T-cell-dependent necroinflammatory liver disease, beginning between postnatal days 7 and 10. 22 In contrast, 129/CF-1-TGF-b1 À/À mice do not develop necroinflammatory liver disease, but succumb to CD4
þ -T-cell-dependent autoimmune pathologies involving other organs. 31, 32 To determine whether the H-2 d haplotype is necessary for the development of necroinflammatory liver disease in BALB-background TGF-b1 À/À mice, TGF-b1 À/À mice (and littermate controls) from the various backgrounds were euthanized at day 11-12. Plasma samples were collected for transaminase analyses (Figure 1) , and livers were dissected out for histologic analyses (Figures 2 and 3) . In 129/CF-1-TGF-b1 À/À mice, plasma AST and ALT levels were not elevated compared with littermate TGF-b1 þ / þ mice, and were only slightly elevated compared with littermate TGF-b1 þ /À mice ( Figure 1 ; Table 2 ). In BALB/c-TGF-b1 À/À mice, by contrast, plasma AST and ALT levels were greatly elevated, compared either with littermate control mice or with 129/CF-1-TGF-b1 À/À mice. These data are consistent with our previously published results. 21 For the BALB H-2 congenic TGF-b1 À/À mice, results were not distinguishable from those observed for BALB/c-TGF-b1
mice. That is, plasma AST and ALT levels were greatly elevated in BALB.B-TGF-b1
À/À mice and in BALB.K-TGF-b1 À/À mice, compared with their respective littermate control mice. Furthermore, plasma AST and ALT levels in BALB.B-TGF-b1
À/À mice and in BALB.K-TGF-b1 À/À mice were not statistically different from those observed for BALB/c-TGFb1 À/À mice, but were highly statistically different from those observed for 129/CF-1-TGF-b1 À/À mice. We inspected livers at the macroscopic and microscopic levels. Grossly, regardless of H-2 haplotype, all BALB-background (BALB/c, BALB.B, BALB.K) TGF-b1 À/À livers had similar lesions, consisting of mottled patchy discoloration of all lobes that probably reflects areas of hemorrhagic necrosis (data not shown). By contrast, 129/CF-1-TGF-b1 À/À livers were grossly normal, and indistinguishable from littermate control livers.
Histologic analyses of livers from BALB/c-TGFb1 À/À mice showed necroinflammatory liver disease, but the histologic features were distinct from those 30 and data in Table 1 ), H-2 haplotype is not a genetic determinant of embryonic lethality of BALB-background TGF-b1 À/À conceptuses. c F1 pups were generated from BALB/c-TGF-b1 +/À mice crossed with 129/CF-1-TGF-b1 +/À mice. The (À/À:+/+) ratio is B1, indicating that the BALB-background phenotype of a (À/À:+/+) ratio of B0.2 is recessively inherited in this cross. of human AIH. In humans, AIH is characterized by a mixed inflammatory infiltrate, predominantly composed of lymphocytes and plasma cells, interface hepatitis, and variable degrees of hepatocellular necrosis and portal fibrosis. As compared with control livers (Figure 2a) , BALB/c-TGF-b1 À/À livers showed confluent hepatocellular necrosis, predominantly in a subcapsular distribution (Figure 2b ). There was no associated peritoneal inflammation (not shown). Centrilobular necrosis could also be seen in deeper liver parenchyma, away from the hepatic capsule (Figure 2c ). High-power examination revealed an associated mixed inflammatory infiltrate, with polymorphonuclear cells a prominent feature (Figure 2d) . Notably, plasma cells were absent, and significant portal inflammation, interface hepatitis, and fibrosis were not commonly seen (Figure 2e ), features that distinguish this pathology from that typically observed in human AIH.
We examined the histology of livers from TGFb1 À/À mice on the other backgrounds. Livers from 129/CF-1-TGF-b1 À/À mice were normal and lacked the distinct widespread hepatocellular necrosis observed in BALB/c-TGF-b1 À/À mice (Figure 3a) . In the H-2 congenic BALB-TGF-b1 À/À livers, histopathology was similar to that observed in BALB/c-TGF-b1 À/À livers. That is, confluent subcapsular and centrilobular hepatocellular necrosis with an associated mixed inflammatory infiltrate dominated by neutrophils was observed in livers from both BALB.B-TGF-b1 À/À mice (Figure 3b ) and BALB.K-TGF-b1 À/À mice (Figure 3c ). Extramedullary hematopoiesis (EMH), most prominently seen within and adjacent to portal tracts, was a common feature of livers from all mice at age 11-12, but there was no difference in the extent or pattern of EMH between any of the groups studied.
In additional studies, we bred BALB/c-TGF-b1 Table 3 ). F1-TGF-b1 À/À plasma AST and ALT levels were significantly different from those measured from BALB/c-TGF-b1 À/À plasma. F1-TGFb1 À/À plasma AST levels were not different from those measured from 129/CF-1-TGF-b1 À/À plasma. While F1-TGF-b1 À/À plasma ALT levels were somewhat elevated compared with 129/CF-1-TGF-b1 À/À plasma ALT levels, this appears to be due more to an effect of an overall increased level of ALT in F1-background plasma in general (see data for F1 littermate controls; Figure 4 ), than to an effect specific to the absence of TGF-b1. Moreover, histologic analyses of eleven F1-TGF-b1 À/À livers showed no evidence of the hepatocellular necrosis and acute inflammation characteristic of BALBbackground TGF-b1 À/À livers (Figure 3d ). Taken together, these results show that the BALB/c-background susceptibility to necroinflammatory liver disease in TGF-b1 À/À mice is recessively inherited in this F1 cross. Importantly, since F1 mice inherit a single H-2 d haplotype from the BALB/c parent, these data also show that harboring the H-2 d haplotype is not sufficient for liver disease susceptibility in TGFb1 À/À mice. The finding of subcapsular necrotic changes in BALB-background TGF-b1 À/À livers suggested the possibility that the etiology of liver disease in these mice might be secondary to systemic ischemia due to hypoperfusion. For this reason, we assessed the histology of hearts from BALB/c-TGF-b1 þ / þ control mice (Figure 5a ) and BALB/c-TGF-b1 Table 2. moderate to severe lymphocytic infiltration of the myocardium, sometimes associated with myocyte damage, reminiscent of autoimmune-mediated myocarditis. In contrast, hearts from 129/CF-1-TGF-b1 À/À mice of this age were relatively free of lymphocytic infiltration (Figure 5c ). Although the presence of myocardial inflammation may suggest a possible ischemic etiology for the hepatocellular damage observed in BALB/c-TGF-b1 À/À mice, no other histopathological signs of systemic hypoperfusion were identified in any other organ examined, including the kidney (Figure 5d ), bowel ( Figure  5e ), and brain (Figure 5f ). Also, our previous work 21, 22 showed that liver pathology does not develop in BALB/c-TGF-b1 À/À mice that also lack either all adaptive lymphocytes, only CD4 þ T cells, or the Th1 cytokine IFN-g, confirming that the etiology of the liver damage is Th1-mediated autoimmunity. The distinctive pathology and rapid kinetics associated with autoimmune liver disease in BALB/c-TGF-b1 À/À mice underscore the significant differences in pathogenesis between this model system and human AIH. While these differences limit the degree to which the current findings are directly applicable to human AIH, the current work demonstrates the existence, at least in mice, of genetic determinants distinct from the MHC that determine susceptibility to T-cell-mediated autoimmune hepatocellular injury.
Discussion
The BALB/c H-2 d haplotype is neither necessary nor sufficient for the development of necroinflammatory liver disease in BALB-background TGF-b1 À/À mice. This finding was unexpected for several reasons. First, in human AIH, MHC haplotype is an important genetic risk factor, and indeed, AIH is notable as one of the initial autoimmune diseases for which an MHC association was identified. 4 Second, in several other murine organ-specific autoimmune disease models, MHC (H-2) haplotype plays an important and perhaps dominant role in genetic susceptibility. Third, necroinflammatory liver disease in BALB/c-TGF-b1 À/À mice is dependent upon CD4 þ T cells, and H-2 haplotype is the key genetic restriction element molding the peripheral CD4 þ T-cell receptor (TCR) repertoire. For these reasons, we hypothesized that the BALB/c-specific H-2 d haplotype is an important genetic risk factor for the development of necroinflammatory liver disease in TGF-b1 À/À mice. The availability of BALB-background mice congenic for other haplotypes at the H-2 locus (BALB.B and BALB.K) allowed us to test this hypothesis directly and rigorously. The data clearly disprove our hypothesis. That is, the development of necroinflammatory liver disease in BALB-background TGF- Table 3 . F1: Intercross between 129/CF-1-TGF-b1 þ /À mice and BALB/c-TGF-b1 þ /À mice. suggest that a locus or loci distinct from the mouse MHC locus H-2 is/are the principal genetic determinants of necroinflammatory liver disease in this model of autoimmune hepatocellular injury. Our preliminary assessment of the H-2 haplotype(s) present in 129/CF-1-TGF-b1 À/À mice is consistent with this conclusion. We tested the H-2 haplotype of cells from four male and four female 129/CF-1-TGF-b1
þ /À breeder mice in our colony using our available typing reagents, and all eight were reactive with anti-H-2 b mAb, but none were reactive with anti-H-2 d mAb or anti-H-2 k mAb (TJK, unpublished). Therefore, it is likely that the 129/CF-1-TGF-b1
À/À mice evaluated in the current study are uniformly H- mice is further evidence to support the conclusion that a genetic locus or loci unlinked to H-2 regulate(s) the development of liver damage in TGF-b1 À/À mice. These data permit the additional conclusion that the class II structural complex I-E is not a contributor to liver disease. There are two structural class II complexes in mouse, termed I-A, and I-E, each of which is a heterodimeric structure composed of an alpha chain and a beta chain. I-E is not expressed from the H-2 b locus due to a mutation in the I-Ea gene, 33 but is expressed from the H-2 d or H-2 k loci. Therefore, since BALB.B-TGF-b1 À/À mice develop liver injury, we may conclude that the I-E complex is dispensable for the development of necroinflammatory liver disease in TGF-b1 À/À mice. This implicates the I-A complex, and peptides presented on I-A, as responsible for the development of necroinflammatory disease in this CD4 þ Tcell-dependent model of autoimmune hepatocellular injury. The repertoire of peptides presented by class II molecules has been difficult to establish owing to the size heterogeneity of class II peptides. While some studies using synthetic peptides indicate little specificity in the peptide repertoire bound by different alleles of class II MHC complexes, 34 ,35 a recent study analyzing naturally processed peptides shows a high degree of specificity in peptide selection by I-A alleles. 36 Allelic specificity in peptide selection may be a function of structural differences between residues found in the peptide binding pockets of the respective allelic I-A molecules. 37 À/À mice, livers are confronted with large numbers of activated Th1 cells. In the former, however, there is little to no hepatocellular damage, whereas in the latter, hepatocellular damage is extensive and widespread. We speculate that the relevant regulatory locus (or loci) may exert its/their effects not in the immune cell compartment, but rather in the hepatocellular compartment, for example by regulating the sensitivity of hepatocytes to apoptotic signals delivered by T cells or other effector cells, such as IFN-g, TNF-a, or Fas Ligand.
The etiology of the severe necroinflammatory liver disease observed in BALB/c-TGF-b1 À/À mice is not entirely clear. The subcapsular and centrilobular pattern of hepatocellular necrosis associated with polymorphonuclear cells resembles that seen in ischemic hepatitis, a possibility made more plausible due to the presence of myocarditis-like lymphocytic inflammmatory infiltrates in the hearts of BALB/c-TGF-b1 À/À mice. However, other evidence argues against global hypoperfusion as the sole cause for the hepatic pathology observed in this study, as ischemic-type necrosis was not found at necropsy in organs that are particularly susceptible to this type of injury, such as bowel, kidney, and brain. In addition, prior experiments performed by our group have demonstrated that intrahepatic CD4 þ T cells from TGF-b1 À/À mice have increased cytolytic activity. 22 Moreover, BALB/c-TGF-b1
À/À IFN-g À/À double knockout mice do not exhibit hepatocellular necrosis despite the presence of myocardial lymphocytic infiltrates. 21 These data suggest that the hepatocellular damage in TGF-b1 À/À mice is immune mediated, and not due to systemic ischemia. Indeed, BALB/c-TGF-b1 À/À mice that are also deficient in all adaptive B and T cells or only the CD4 þ T lymphocyte subset do not develop hepatocellular injury, 22 demonstrating that adaptive CD4 þ T lymphocytes play a critical role in mediating necroinflammatory liver disease. CD4 þ T cells from BALB/c-TGF-b1 À/À livers produce very high levels of both IFN-g and TNF-a. Local high concentrations of these cytokines in liver may participate in hepatocellular damage. Recently, Schramm et al 39 showed that TGF-b1 acting directly on T cells is important for hepatoprotection, as transgenic mice expressing a dominant-negative TGF-b receptor specifically in T cells were rendered much more susceptible to liver disease than control animals in a mouse model of inducible T-cell-mediated autoimmune hepatitis. Interestingly, T cells from these mice produced high levels of IFN-g. Thus, TGF-b1 may protect the liver indirectly, at least in part, by inhibiting Th1 differentiation, and subsequent intrahepatic production of IFN-g and other hepatotoxic substances by T cells.
In conclusion, the identification of allelic genetic loci other than MHC that regulate the development of autoimmune-mediated hepatocellular damage has been difficult heretofore, owing to the low prevalence of AIH and the reliance on candidate gene disease association studies. The development of the TGF-b1
À/À mouse model of autoimmune hepatocellular damage allows for the possibility of locating and identifying such loci through more efficient and robust genetic methods, such as the use of interspecific crosses and genomewide quantitative trait locus analyses, 40 which are currently underway in our laboratory.
